Print Page   |   Contact Us   |   Sign In   |   Join Today
VABIO E-News January 21, 2016
Share |

Become a Member

VABIO E-News: January 21, 2016 Edition

Focus Around Virginia 
A Word from CEO Jeff Gallagher

Members and Friends of Virginia Bio,

The 2016 legislative session has kicked off here in Richmond and its time for everyone to make a difference. This General Assembly faces an urgent need to develop smart policies to jumpstart diversified, high-tech, high-wage job and economic growth across the state. Investing in the bioscience/biomedical fields can produce the growing economic returns Virginia needs to provide great jobs and support the state budget. Over the last year, Virginia Bio has led industry and research university leaders on crafting a comprehensive plan to dramatically grow the bioscience economy for decades to come (details can be found here).

Most of these important programs support the growth of all technology industries. Others focus on biosciences to jumpstart the tremendous potential untapped in the state. Taken together, they complement and complete one another to form a strong framework on which private industry will build an industry of national prominence. The plan is already reflected in the Introduced Budget. We urge the General Assembly to maintain and support the Virginia Bio plan as it develops its budget amendments.

For complete article click here.

Thank you to our Premium Partners



Gold Partners:

Silver Partners:


In this issue
focus around Virginia
VABIO Articles
VABIO Community News
VABIO Anniversaries
VABIO Calendar

SVA STEM-H Summit Returns

VABIO Community News 
VABIO Member Anniversaries 

VABIO Events
Virginia Bio Calendar


NIH Unveils FY2016–2020 Strategic Plan

The National Institutes of Health (NIH) released the NIH-Wide Strategic Plan, Fiscal Years 2016–2020: Turning Discovery Into Health, which will ensure the agency remains well positioned to capitalize on new opportunities for scientific exploration and address new challenges for human health. Developed after hearing from hundreds of stakeholders and scientific advisers, and in collaboration with leadership and staff of NIH’s Institutes, Centers, and Offices (ICOs), the plan is designed to complement the ICOs’ individual strategic plans that are aligned with their congressionally mandated missions.

For complete article click here.

RestorGenex and Diffusion Pharmaceuticals Form Merger Agreement

RestorGenex Corporation and Diffusion Pharmaceuticals LLC, a privately‐held biotechnology company, have entered into a definitive merger agreement under which a newly formed subsidiary of RestorGenex will merge with and into Diffusion in an all‐stock transaction, with Diffusion surviving as a wholly owned subsidiary of RestorGenex. Upon completion, RestorGenex will issue to Diffusion equity holders shares of RestorGenex common stock such that the current equity holders of Diffusion will own approximately 83% of the combined company’s outstanding shares and current stockholders of RestorGenex will own approximately 17%.

For complete article click here.

BIO Gets New Name and Summarizes Legislation Ready for Obama to Sign

BIO recently communicated a summary of packages that were recently passed by the Senate, the combined omnibus appropriations and tax extenders package 65-33 (27 Rs and 38 Ds). The omnibus passed the House 316-113 and the extenders package was completed 318-109. The legislation now goes to President Obama to be signed into law. That concludes all major Congressional business for the rest 2015.

For complete article click here.

On another note, to better reflect the remarkable progress and groundbreaking innovations its members achieve in healing, fueling and feeding the world, Biotechnology Industry Organization is changing its name to Biotechnology Innovation Organization. The organization will continue to use the shortened, “BIO” name.

For complete article click here.

Inova Health System and George Mason University Partner on Research and Facilities

George Mason University and Inova are combining their extensive and complementary resources to conduct personalized medicine research. This work will lead to new patient cures and treatments for a variety of diseases and groundbreaking disease prevention strategies.

For complete article click here.

Qore Invests $12.8m in VA Relocation

Qore Systems, LLC will invest $12.8 million to relocate from Arizona and establish its first Virginia operation in Highlands Business Park, owned and operated by Smyth County and Washington County. The company is a developer, manufacturer and distributor of Qore-24, the world's only antimicrobial hand purifier that effectively kills germs for up to 24 hours. Virginia successfully competed against North Carolina for the project, which will create 140 new jobs.

For complete article click here.

Theresa Mayer Named VP at VT

Theresa S. Mayer, a leading nanotechnology researcher and the associate dean for research and innovation in Penn State’s College of Engineering, has been named Virginia Tech’s new vice president for research and innovation.

For complete article click here.

HemoShear Races to Treatments and Collaborates with Pfizer

HemoShear Therapeutics and Children's National Health System released study results that demonstrated successful restoration of propionic acidemia (PA), a rare metabolic disorder, using explanted liver tissue from a child with the disease. This study, published in the Journal of Molecular Genetics and Metabolism, demonstrated a novel method of recreating the disease in the laboratory for discovery of treatments for PA that may extend the lives of these children and possibly cure the disease.

For complete article
click here.

HemoShear will be initiating the next stage of a multi-year collaboration with Pfizer. Under the terms of the agreement, which combines the scientific and technical expertise of both companies, HemoShear will leverage its proprietary discovery platform, REVEAL-Tx™, with the aim of developing a predictive model for preclinical drug-induced vascular injury. 

For complete article click here.

NC Ag Biotech Showcase: Apply by January 22, 2016 for Pitch Presentations


For the fourth year NCBiotech is convening entrepreneurs, investors, and technology scouts for the Ag Biotech Entrepreneurial Showcase. On May 18, ag biotech investment firms, global ag biotech companies, university research labs, technology transfer offices, and support organizations will gather for information sharing, networking, and partnering.

For complete article click here.

U. Va Developed Artificial Pancreas to Undergo Final Tests

A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning early this year.

For complete article click here.

Southern Virginia STEM-H Summit Returns for Fourth Year

The fourth Annual Southern Virginia STEM-H Summit is a two day event being held on March 22 & 23, 2016 at the Institute for Advanced Learning & Research in Danville, Virginia. Hosted by the Southside Higher Education Coalition, the summit brings together all regional stakeholders, business and community leaders, teachers and students, around the subject of STEM- H education and workforce development in southern Virginia. A goal of the summit is to foster conversations about what high quality STEM-H education looks like, along with the skills required for a truly "STEM-capable" workforce.

For complete article click here.

Virginia Bio Foundation Offering 2016 Bioscience Internship Matching Funds
The Virginia Bioscience Foundation (VBF), an initiative of the Virginia Biotechnology Association (Virginia Bio), is offering matching funds of $1,000 each for summer internships.

The criteria are as follows: The biotechnology or medical device company must be planning to match or exceed the $1,000 award for the intern and the intern must be currently enrolled in a Virginia institution of higher education or be a resident of the Commonwealth currently enrolled in an institution of higher education.

For complete article click here.

Virginia Bio Welcomes New Members to its Board of Directors

Virginia Bio, the premier statewide non-profit association representing life science industry in the Commonwealth of Virginia, elected five new members to their Board of Directors for a term of three years. The election took place in December at the Virginia Bio Annual Membership in Richmond, Virginia. The newly elected members include Elaine Horn-Ranney, co-founder and CEO of Tymanogen, Warren Martin, Partner Cherry Bekaert, John Niederhuber, CEO Inova Translational Medicine Institute, Chris Penet, Vice President BIO-CAT, Thomas Voss, Director of the Center for Infectious Diseases and Deputy Site Head of SRI Shenandoah Valley.

For complete article click here.

Welcome New Member: Resilicore
Resilicore is a specialist professional services organization. Businesses are more than ever before, facing rapid and unforeseen challenges and events, which cause deep structural damage to their organizations. With expertise in Financial/Capital Planning, Budgeting Forecasting and Reporting and Resilicore provides services that both find and preserve cash and identify new revenue opportunities.

For more information please visit their website.


Welcome New Member: ResourcePath
ResourcePath is a research support company founded by pathologists with extensive experience in human and animal disease. ResourcePath provides support for investigators as an institutional core facility would, but without some of the institutional barriers that slow research progress. ResourcePath provides histology, immunohistochemistry, digital imaging, pathologist review and genomics services to researchers from academia, government and private sector on a simple fee for service, first-come, first-serve basis.

For more information please visit their website.


Welcome New Member: Northrop Grumman
A major component of global defense is protecting and promoting the health and well-being of the global community. The challenges facing the healthcare system are complex and ever changing. To stay ahead of the challenge, Northrop Grumman integrates health expertise and information technology. The team includes both technical/IT-focused backgrounds as well as those with medical and health-related skills.

For more information please visit their website.


VABIO Community News TO TOP

Carrie Roth, President/CEO of the Virginia Biotechnology Research Park, and her husband Doug will be honored at the Juvenile Diabetes Research Foundation Central Virginia Chapter Gala in Richmond on February 27th for their efforts in support of finding a cure for Type 1 diabetes. They are the first non-type 1 family to be recognized by the Chapter.

Professor Brian T McMahon, Associate Dean for Research and Innovation at VCU, just returned from the University Luxembourg where he delivered a speech on disability policy in the U.S.  While there, he successfully completed his application for dual citizenship (known as "reclamation of nationality") in the Grand Duchy of Luxembourg, the birthplace of his maternal grandparents.

Barry Matherly, President/CEO of Greater Richmond Partnerships has been elected Chairman of the International Economic Development Council.

Jeff Gallagher, CEO of Virginia Bio has been elected to the board of Virginia Biosciences Health Research Corporation (VBHRC/the Catalyst).

Doug Sbertoli, the former Executive Vice President and General Counsel for Health Diagnostic Laboratory, Inc.  recently joined New Dawn Advisors, LLC.  New Dawn is a consulting business that provides advisory services to companies in various industries, with a focus on those in the healthcare and biotechnology space.
VABIO Member Anniversaries TO TOP

Virginia Bio would like to thank our long term members who have recently celebrated their membership anniversaries:


Virginia Bio would also like to thank our members renewing for the first time:



Event: FBS Market Dynamics and Alternatives Webinar
Where: Live Streaming
When:Thursday, February 4th, 12:00pm-1:00pm
Details: The purpose of this talk is to discuss the FBS market and factors that influence it's price and availability. The current market is experiencing unprecedented dynamics. Mergers/divestitures, raw material shortages, and product recalls influence the availability of FBS and increase production costs that trickle down to the researchers. Beyond that, we will discuss what your colleagues have done in response to this unpredictable market to continue their research without breaking the bank.
Registration: Click here to register

Event: Annual BIO CEO & Investor Conference
Where: The Waldorf Astoria New York, New York
When: February 8-9
Details: Virginia Bio members receive 20% discount for conference. Please contact Liz Kelly for the discount codes. For more information or registration click here.

Event: Virginia Bio Commercialization Luncheon - February 2016
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, February 11, 11:30am - 1:30pm
Details: “Top 3 by 2023”: Medimmune’s leadership of private and public policy initiatives to grow the Maryland/DC/Virginia bioscience community into national prominence.
Leaders from Medimmune responsible for creating and implementing this regional development strategy will discuss their vision and their efforts, with emphasis on the potential impact on and involvement of the bioscience industry across Virginia.
Speakers include Reg Seeto and Jarrod Borkat
Registration: Click here to register.
Sponsors: Greater Richmond Partnership, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

Event: Virginia Bio 2016 General Assembly Reception
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, January 14, 11:30am - 1:30pm
Details: This year more than ever, we need your support of the Virginia Bioscience Economy Initiative. Meet and mingle with state officials at our annual Virginia Bio 2016 General Assembly Reception. Join your colleagues for an evening of cocktails and policy and let your voice count.
Registration: Click here to register.
Sponsors: Hosted by Virginia Biotechnology Research Park and Sponsored by We Work For Health, Williams Mullen, Lilly, Pfizer, Teva, CIT, and PhRMA

Event: Virginia Bio Commercialization Luncheon - March 2016
Where: Virginia Biotechnology Research Park, Richmond, VA
When: Thursday, March 10, 11:30am - 1:30pm
Details:The changing landscape for medical device companies.
Medical devices help health care providers deliver quality health care services. From tongue depressors to pacemakers, from CT Scans to kidney dialysis machines, a wide array of medical devices are available. The United States has the largest medical device market in the world and is expected to continue growing very quickly. Investment in medical device research and development in the domestic sectors is more than twice the average for all U.S. manufactures. Speakers include, Elaine Horn-Ranney, Alan Connor, and Gary Warren.
Registration: More details coming soon
Sponsors: Greater Richmond Partnership, VCU Innovation Gateway, We Work For Health and the Virginia Biotechnology Research Park

APRIL 12-13
Event: BIO's 2016 Fly-In
Where: Washington, DC
When: Tuesday, April 12-Wednesday, April 13, 2016
Details: Once a year, BIO hosts the Legislative Day Fly-In, inviting biotechnology executives from across the country to come to Washington D.C. for a day and a half of legislative briefings and advocacy. BIO will schedule all congressional meetings and provide attendees with a robust legislative briefing prior to their visits on Capitol Hill. Attendees meet in small groups with the congressional Members and senior staff of the attendee’s congressional delegation. Each group will be accompanied by a BIO staff representative to all visits.The changing landscape for medical device companies.
Registration: Click here to register


Virginia Bio, was formed in 1992 and incorporated in the Commonwealth of Virginia as a non-profit association. The purpose of the Association is to promote the biotechnology industry in Virginia, expand the knowledge and expertise of Virginia's businesses concerning biotechnology through seminars, educational publications and other means, to enhance public awareness of the biotechnology industry in Virginia and the scientific, economic and other benefits it provides, and to represent the interests of the biotechnology industry in Virginia before federal, state and local legislators and regulators.  We provide a forum for members and their guests to get to know each other and the many bioscience companies operating today in Virginia and serving our biotech community. We coordinate information among the many agencies and organizations interested in biotechnology.

To learn more about Virginia Bio and how you can get involved, Click Here

This is the E-newsletter of Virginia Bio, a non-profit organization dedicated to supporting the Life Sciences community in the Commonwealth of Virginia. New subscribers can join at our website,  
more Events

Webinar; R&D Tax Credits for Virginia Companies

10/26/2016 » 10/27/2016
UVA Fall Job & Internship Fair

Premium Members

Membership Software Powered by®  ::  Legal